Quarterly report pursuant to Section 13 or 15(d)

Uncategorized Items - imle-20150630.xml

v3.2.0.727
Label Element Value
Net loss attributable to TranBioTec, Inc. us-gaap_NetIncomeLoss $ (167,331)
Net loss attributable to TranBioTec, Inc. us-gaap_NetIncomeLoss $ (208,327)
Non employee stock options [Member]  
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range, Outstanding Options, Weighted Average Exercise Price us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1 $ 0.10